These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14747434)

  • 21. [Clinical and pathological characterization of antineutrophil cytoplasmic antibody associated small vasculitis in children].
    Zhou JH; Tang JH; Shi H; Liu TL; Qiu LR; Chen Y
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):408-11. PubMed ID: 15265421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fifty years of antineutrophil cytoplasmic antibodies (ANCA) testing: do we need to revise the international consensus statement on testing and reporting on ANCA?
    Tervaert JW; Damoiseaux J
    APMIS Suppl; 2009 Jun; (127):55-9. PubMed ID: 19515141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dual-fixed neutrophil substrate improves interpretation of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.
    Lin MW; Silvestrini RA; Culican S; Campbell D; Fulcher DA
    Am J Clin Pathol; 2014 Sep; 142(3):325-30. PubMed ID: 25125622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis.
    Aslam A; Newman TL; Misbah SA
    J Clin Pathol; 2003 Oct; 56(10):775-7. PubMed ID: 14514783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children.
    Yu F; Huang JP; Zou WZ; Zhao MH
    Pediatr Nephrol; 2006 Apr; 21(4):497-502. PubMed ID: 16491416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the new algorithm in ANCA testing].
    Spoerl D; Bühler S; Marchal O; Roux-Lombard P
    Rev Med Suisse; 2019 Apr; 15(645):732-735. PubMed ID: 30942971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic outcome and indications for testing in patients with positive ANCA at a Canadian tertiary care centre.
    Chehroudi C; Booth RA; Milman N
    Rheumatol Int; 2018 Apr; 38(4):641-647. PubMed ID: 29243051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis.
    Harris A; Chang G; Vadas M; Gillis D
    J Clin Pathol; 1999 Sep; 52(9):670-6. PubMed ID: 10655988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.
    Avery TY; Bons J; van Paassen P; Damoiseaux J
    Lupus; 2016 Jul; 25(8):917-24. PubMed ID: 27252270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CARI guidelines. ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis.
    Luxton G; Langham R;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S17-23. PubMed ID: 18713120
    [No Abstract]   [Full Text] [Related]  

  • 31. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
    Savige J; Pollock W; Trevisin M
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
    Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
    J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antineutrophil cytoplasmic autoantibodies (ANCA)--markers in diagnosis and monitoring systemic vasculitides.
    Cristea A; Badea T; Bodizs G; Olinic N
    Rom J Intern Med; 1995; 33(1-2):37-46. PubMed ID: 8535351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
    Xin G; Zhao MH; Wang HY
    Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
    Nakano H; Ozaki S
    Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine.
    Choi HK; Slot MC; Pan G; Weissbach CA; Niles JL; Merkel PA
    Arthritis Rheum; 2000 Nov; 43(11):2488-92. PubMed ID: 11083272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-neutrophil cytoplasmic antibodies (ANCA) in the clinical forms of leprosy.
    Freire BF; Ferraz AA; Nakayama E; Ura S; Queluz TT
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):475-82. PubMed ID: 10347568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antineutrophil cytoplasmic antibodies: clinical characteristics of 10 patients with the perinuclear pattern of immunofluorescence on ANCA testing.
    Ecklund SR; Saluta GS; Agudelo CA; Pisko EJ
    South Med J; 1992 Feb; 85(2):132-8. PubMed ID: 1738878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceruloplasmin levels in antineutrophil cytoplasmic antibody-positive patients.
    Baskin E; Bakkaloglu A; Besbas N; Hascelik G; Saatci U; Gök F; Ozen S
    Pediatr Nephrol; 2002 Nov; 17(11):917-9. PubMed ID: 12432434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.